Search

Your search keyword '"Julie Butters"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Julie Butters" Remove constraint Author: "Julie Butters"
38 results on '"Julie Butters"'

Search Results

1. Tackling cardiometabolic risk in the Asia Pacific region

2. Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes

3. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

4. Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study

5. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

6. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

7. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

8. Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region

9. Tackling cardiometabolic risk in the Asia Pacific region

10. Coronary artery echo-attenuated plaques in acute coronary syndromes: a serial intravascular ultrasound imaging study

11. Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism

12. Effect of serial infusions of CER-001, a pre-β High-density lipoprotein mimetic, on coronary atherosclerosis in patients following acute coronary syndromes in the CER-001 atherosclerosis regression acute coronary syndrome trial: A randomized clinical trial

13. Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden

14. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs

15. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

16. Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism

17. P2334Association between cholesterol efflux capacity and coronary plaque lipid composition on near infrared spectroscopy

19. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study

20. Association Of Cholesterol Efflux Capacity With Regression Of Coronary Atherosclerosis

21. Predictors of radiation-induced gastrointestinal morbidity: a prospective, longitudinal study following radiotherapy for carcinoma of the prostate

22. Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden

23. HIgh-density lipoprotein cholesterol as a determinant of change in coronary plaque lipid burden assessed by near infrared spectroscopy

24. Gender related differences of serial change in coronary plaque composition

25. Feasibility study on the MammoSite in early-stage breast cancer: Initial experience

27. Relationship of Cholesterol Efflux Capacity with Coronary Plaque Lipid Composition on Near Infrared Spectroscopy

28. Short-Term Changes in Spotty Calcification and Burden of Coronary Atherosclerosis: Insights into the Interface Between Plaque Composition and Burden

29. Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate

30. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial

31. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial

32. In Reply to Ohri et al

33. Mo2000 Image Guided Radiation Therapy (IGRT) With Endorectal Balloon (ERB) for Carcinoma of the Prostate (CaP) Reduces Gastrointestinal (GI) Symptoms at 1 Year Versus IGRT Alone

34. Sa2037 Image Guided Radiation Therapy (IGRT) With Endorectal Balloon (ERB) for Carcinoma of the Prostate (CAP) Reduces Acute Gastrointestinal (GI) Sequelae Compared With Igrt Alone

35. Tu2006 Image Guided Radiation Therapy (IGRT) Combined With Brachytherapy (BT) Impacts Less Adversely on General and Bowel Health Related Quality of Life (HRQoL) Compared to Igrt Alone for Carcinoma of the Prostate (CAP)

36. Radiation-Induced Anorectal Dysfunction Remains Persistent Whilst Rectal Bleeding Stabilises After Radiation Therapy (RT) for Prostate Carcinoma (CAP)

37. Randomised Trial of Argon Plasma Coagulation (APC) Therapy Verses Topical Formalin for Persistent Rectal Bleeding and Anorectal Dysfunction After Radiation Therapy (RT) for Carcinoma of the Prostate (CAP)

38. 481 Cytokinesis Blocked Micronucleus (Cbmn) Assay Is Predictive of Gastrointestinal (GI) Sequeale 2 Years Following Radiation Therapy (RT) for Prostate Carcinoma (CAP) Whilst Micronutrients Reduce Their Severity

Catalog

Books, media, physical & digital resources